FT
BMY icon

Fiduciary Trust’s Bristol-Myers Squibb BMY Stock Holding History

Fiduciary Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.05M Sell
132,668
-1,671
-1% -$97.4K 0.1% 125
2025
Q4 		$7.25M Sell
134,339
-10,889
-7% -$524K 0.08% 135
2025
Q3 		$6.55M Sell
145,228
-8,403
-5% -$392K 0.07% 145
2025
Q2 		$7.11M Sell
153,631
-6,497
-4% -$319K 0.09% 136
2025
Q1 		$9.77M Sell
160,128
-7,487
-4% -$436K 0.13% 102
2024
Q4 		$9.48M Sell
167,615
-11,945
-7% -$667K 0.13% 108
2024
Q3 		$9.29M Sell
179,560
-1,865
-1% -$87.5K 0.13% 110
2024
Q2 		$7.53M Sell
181,425
-32,747
-15% -$1.47M 0.11% 120
2024
Q1 		$11.6M Sell
214,172
-8,036
-4% -$409K 0.18% 89
2023
Q4 		$11.4M Buy
222,208
+30,257
+16% +$1.59M 0.19% 88
2023
Q3 		$11.1M Sell
191,951
-1,389
-0.7% -$85.1K 0.2% 82
2023
Q2 		$12.4M Buy
193,340
+3,700
+2% +$248K 0.22% 77
2023
Q1 		$13.1M Buy
189,640
+4,790
+3% +$338K 0.24% 73
2022
Q4 		$13.3M Buy
184,850
+7,558
+4% +$570K 0.26% 75
2022
Q3 		$12.6M Buy
177,292
+8,978
+5% +$651K 0.27% 69
2022
Q2 		$13M Sell
168,314
-752
-0.4% -$57.3K 0.27% 70
2022
Q1 		$12.3M Buy
169,066
+1,707
+1% +$115K 0.22% 88
2021
Q4 		$10.4M Sell
167,359
-4,494
-3% -$264K 0.17% 107
2021
Q3 		$10.2M Buy
171,853
+571
+0.3% +$37.6K 0.18% 104
2021
Q2 		$11.4M Sell
171,282
-11,294
-6% -$736K 0.22% 93
2021
Q1 		$11.5M Sell
182,576
-6,156
-3% -$383K 0.23% 90
2020
Q4 		$11.7M Buy
188,732
+18,515
+11% +$1.14M 0.24% 85
2020
Q3 		$10.3M Sell
170,217
-1,152
-0.7% -$69.3K 0.24% 79
2020
Q2 		$10.1M Buy
171,369
+30,851
+22% +$1.85M 0.25% 81
2020
Q1 		$7.83M Buy
140,518
+11,520
+9% +$704K 0.23% 88
2019
Q4 		$8.28M Buy
128,998
+43,299
+51% +$2.48M 0.19% 103
2019
Q3 		$4.35M Buy
85,699
+5,363
+7% +$252K 0.11% 135
2019
Q2 		$3.64M Sell
80,336
-2,717
-3% -$127K 0.1% 146
2019
Q1 		$3.96M Sell
83,053
-2,970
-3% -$148K 0.11% 137
2018
Q4 		$4.47M Buy
86,023
+849
+1% +$45.6K 0.14% 122
2018
Q3 		$5.29M Sell
85,174
-275
-0.3% -$16.3K 0.15% 125
2018
Q2 		$4.73M Buy
85,449
+648
+0.8% +$35K 0.14% 132
2018
Q1 		$5.36M Sell
84,801
-1,110
-1% -$71.4K 0.17% 123
2017
Q4 		$5.26M Sell
85,911
-2,076
-2% -$130K 0.16% 123
2017
Q3 		$5.61M Sell
87,987
-239
-0.3% -$14K 0.17% 112
2017
Q2 		$4.92M Sell
88,226
-7,191
-8% -$391K 0.15% 119
2017
Q1 		$5.19M Sell
95,417
-2,813
-3% -$154K 0.16% 117
2016
Q4 		$5.74M Sell
98,230
-5,072
-5% -$277K 0.19% 104
2016
Q3 		$5.57M Sell
103,302
-2,908
-3% -$187K 0.19% 104
2016
Q2 		$7.81M Sell
106,210
-1,755
-2% -$124K 0.27% 85
2016
Q1 		$6.9M Buy
107,965
+3,060
+3% +$193K 0.24% 93
2015
Q4 		$7.22M Buy
104,905
+740
+0.7% +$48.9K 0.31% 79
2015
Q3 		$6.17M Buy
104,165
+2,600
+3% +$165K 0.28% 86
2015
Q2 		$6.76M Buy
101,565
+32,932
+48% +$2.17M 0.28% 88
2015
Q1 		$4.43M Sell
68,633
-700
-1% -$43.8K 0.18% 114
2014
Q4 		$4.09M Buy
69,333
+2,050
+3% +$116K 0.17% 114
2014
Q3 		$3.44M Buy
67,283
+80
+0.1% +$4K 0.15% 121
2014
Q2 		$3.26M Sell
67,203
-1,850
-3% -$91.2K 0.14% 129
2014
Q1 		$3.59M Buy
69,053
+2,506
+4% +$133K 0.16% 116
2013
Q4 		$3.54M Buy
66,547
+700
+1% +$35.7K 0.16% 114
2013
Q3 		$3.05M Sell
65,847
-25
-0% -$1.1K 0.14% 122
2013
Q2 		$2.94M Buy
+65,872
New +$2.86M 0.14% 119

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fiduciary Trust's BMY Position: Q1 2026 in Review

Fiduciary Trust reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, selling an estimated $97.4K and leaving 132,668 shares worth $8.05M. The position accounts for 0.1% of the portfolio, ranked #125.

Fiduciary Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fiduciary Trust held 132,668 shares of Bristol-Myers Squibb worth $8.05M as of Q1 2026.
  • Fiduciary Trust sold 1,671 Bristol-Myers Squibb shares in Q1 2026, an estimated $97.4K.
  • Bristol-Myers Squibb made up 0.1% of Fiduciary Trust's portfolio in Q1 2026, its #125 holding.
  • Fiduciary Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's Bristol-Myers Squibb position peaked at $13.3M in Q4 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.